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ABSTRACT
Scientiﬁc reproducibility has been at the forefront of many news stories and there
exist numerous initiatives to help address this problem. We posit that a contributor
is simply a lack of speciﬁcity that is required to enable adequate research repro-
ducibility. In particular, the inability to uniquely identify research resources, such
as antibodies and model organisms, makes it diYcult or impossible to reproduce
experimentsevenwherethescienceisotherwisesound.Inordertobetterunderstand
the magnitude of this problem, we designed an experiment to ascertain the “iden-
tiﬁability” of research resources in the biomedical literature. We evaluated recent
journal articles in the ﬁelds of Neuroscience, Developmental Biology, Immunology,
Cell and Molecular Biology and General Biology, selected randomly based on a
diversity of impact factors for the journals, publishers, and experimental method
reporting guidelines. We attempted to uniquely identify model organisms (mouse,
rat, zebraﬁsh, worm, ﬂy and yeast), antibodies, knockdown reagents (morpholinos
or RNAi), constructs, and cell lines. Speciﬁc criteria were developed to determine if
a resource was uniquely identiﬁable, and included examining relevant repositories
(such as model organism databases, and the Antibody Registry), as well as vendor
sites. The results of this experiment show that 54% of resources are not uniquely
identiﬁableinpublications,regardlessofdomain,journalimpactfactor,orreporting
requirements. For example, in many cases the organism strain in which the experi-
ment was performed or antibody that was used could not be identiﬁed. Our results
show that identiﬁability is a serious problem for reproducibility. Based on these
results,weproviderecommendationstoauthors,reviewers,journaleditors,vendors,
andpublishers.ScientiﬁceYciencyandreproducibilitydependuponaresearch-wide
improvementofthissubstantialprobleminsciencetoday.
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The scientiﬁc method relies on the ability of scientists to reproduce and build upon each
other’spublishedresults.Althoughitfollowsthattheprevailingpublicationmodelshould
support this objective, it is becoming increasingly apparent that it falls short (Haendel,
Vasilevsky & Wirz, 2012; de Waard, 2010). This failure was highlighted in a recent Nature
report from researchers at the Amgen corporation, who found that only 11% of the
academic research in the literature was reproducible by their groups (Begley & Ellis,
2012). Further alarm is raised by the fact that retraction rates, due in large part to a lack
ofreproducibility,havesteadilyincreasedsincetheﬁrstpaperwasretractedin1977(Cokol,
Ozbay & Rodriguez-Esteban, 2008). While many factors are likely at play here, perhaps the
most basic requirement for reproducibility holds that the materials reported in a study
can be uniquely identiﬁed and obtained, such that experiments can be reproduced as
faithfully as possible. Here, we refer to reproducibility deﬁned as the “conditions where
test results are obtained with the same method on identical test materials in diVerent
laboratories with diVerent operators using diVerent equipment” (ISO 5725-1:1994, 1994).
This information is meant to be documented in the ‘materials and methods’ of journal
articles, but as many can attest, the information provided there is often not adequate for
thistask.Suchafundamentalshortcomingcoststimeandresources,andpreventseYcient
turns of the research cycle whereby research ﬁndings are validated and extended toward
new discoveries. It also prevents us from retrospectively tagging a resource as problematic
orinsuYcient,shouldtheresearchprocessrevealissueswithaparticularresource.
Until recently, challenges in resource identiﬁcation and methodological reporting have
been largely anecdotal, but several eVorts have begun to characterize this problem and
enact solutions. The National Centre for the Replacement, Reﬁnement and Reduction
of Animals in Research (NC3R) evaluated methodological reporting in the literature for
in vivostudiesusing rodentmodelsor non-humanprimates.They examined271publica-
tions and reported that only 60% of the articles included information about the number
and characteristics of the animals (strain, sex, age, weight) and approximately 30% of the
articles lacked detailed descriptions of the statistical analyses used (Kilkenny et al., 2009).
Based on this study, the ARRIVE guidelines (http://www.nc3rs.org.uk/page.asp?id=1357)
were developed for reporting of in vivo experiments pertaining to animal research. Other
domain speciﬁc standards have been published such as the Minimum information about
a protein aYnity reagent (MIAPAR) (Bourbeillon et al., 2010) and the high-proﬁle
communication from Nature to address concerns regarding research reproducibility
where they oVered improved standards for reporting life science research (http://www.
nature.com/authors/policies/reporting.pdf). The Neuroscience Information Framework
(NIF; http://neuinfo.org) speciﬁcally developed the Antibody Registry as a means to aid
identiﬁcation of antibodies within published studies, based on a small pilot study which
showed that >50% of antibodies could not be identiﬁed conclusively within published
papers(AEBandrowski,NAVasilevsky,MHBrush,MAHaendel,VAstakhov,PCiccarese,
J McMurry and ME Martone, unpublished data). ISA-TAB provides a generic, tabular
format, which contains metadata standards to facilitate data collection, management,
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reproducibility, the Force11 community has published a set of recommendations for
minimal data standards for biomedical research (Martone et al., 2012) and published a
manifestotoimproveresearchcommunication(Philetal.,2011).TheBioSharinginitiative
(www.biosharing.org) contains a large registry of community standards for structuring
and curating datasets and has made signiﬁcant strides towards the standardization of data
viaitsmultiplepartnershipswithjournalsandotherorganizations.
WhiletheworkhighlightedabovehasoVeredguidancebasedontheperceivedproblem
of inadequate methodological reporting, the fundamental issue of material resource
identiﬁcation has yet to be speciﬁcally characterized using a rigorous scientiﬁc approach.
It is our belief that unless researchers can access the speciﬁc research materials used in
published research, they will continue to struggle to accurately replicate and extend
the ﬁndings of their peers. Until our long held assumptions about a lack of unique
identiﬁability of resources are conﬁrmed with quantitative data, this problem is unlikely
to pique the interest of funding agencies, vendors, publishers, and journals, who are in
a position to facilitate reform. To this end, we report here an experiment to quantify the
extent to which material resources reported in the biomedical literature can be uniquely
identiﬁed.Weevaluated238journalarticlesfromﬁvebiomedicalresearchsub-disciplines,
including Neuroscience, Developmental Biology, Immunology, Cell and Molecular
Biology, and General Biology. Target journals were selected from each category to include
a representative variety of publishers, impact factors, and stringencies with respect to
materials and methods reporting guidelines. In each article, we tracked reporting of ﬁve
typesofresources:(1)modelorganisms(mouse,rat,zebraﬁsh,worm,ﬂy,frog,andyeast);
(2)antibodies;(3)knockdownreagents(morpholinosorRNAi);(4)DNAconstructs;and
(5) cell lines. We developed a detailed set of evaluation criteria for each resource type and
applied them to determinethe identiﬁability of over 1,700 individual resourcesreferenced
inourcorpus.Theresultsofthisexperimentquantifyaprofoundlackofuniqueidentiﬁca-
tionofresearchresourcesinthebiomedicalliteratureacrossdisciplinesandresourcetypes.
Based on these results and the insights gained in performing this experiment, we provide
recommendations for how research resource identiﬁcation can be improved by imple-
mentingsimplebuteVectivesolutionsthroughoutthescientiﬁccommunicationcycle.
METHODS
Journal selection and classiﬁcation
The core of our evaluated corpus was comprised of articles from a set of target journals
thatvariedacrossthreefeatures:researchdiscipline,impactfactor,andreportingguideline
requirements. For research discipline selection, we followed the Institute for Scientiﬁc In-
formation(ISI)categorizationandselectedﬁvejournalsfromCellBiology,Developmental
Biology, Immunology, and Neuroscience. In addition, a non-ISI category (General Biol-
ogy) was included to cover multidisciplinary journals such as Science, Nature, and PLoS
Biology. Within each discipline, care was taken to include journals with a range of impact
factors as reported in the Journal Citation Report from 2011 (Thomson Reuters, 2011).
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impact factor fell into the top, middle, or lowest third for their discipline in this report.
Finally, we selected journals that varied in the stringency of their recommendations for
reporting data about material resources. Journals were assigned to one of three categories:
(1)Stringent ifthejournalrequireddetailedinformationorspeciﬁcidentiﬁerstoreference
materials reported in the manuscript (e.g., required catalog numbers for antibodies);
(2) Satisfactory if the journal provided only limited recommendations for structured
reporting or resource identiﬁers, but did not restrict space allocated for this information;
and (3) Loose where minimal or no reporting requirements for materials and methods
wereprovided,and/orthelengthofmaterialreportingspacewasrestricted.Notethatthese
guidelinesweretheonesineVectatthetimeofmanuscriptselection(January18,2013).
Article selection
Articles in the core collection of our corpus were selected randomly by performing a
PubMed search ﬁltered for each journal and using the ﬁrst ﬁve publications returned on
January 18, 2013 (all publications were from 2012–2013). This approach was adequate
for all journals except Nature and Science, which cover a very general scientiﬁc spectrum
suchthattopPubMedhitsoftenfailedtoincludetheresourcetypesevaluatedinourstudy.
For these journals, the most recent articles that were likely to contain our resources were
selected directly from the publisher’s website. Recent publications were chosen for our
corpus deliberately to reduce the chance that they had been curated by a model organism
database (MOD) or other curatorial eVorts, which could skew results by providing
additional curated data not reported or accessible from the original article alone. NIF
had also noted in a pilot project that the identiﬁability of reagents decreases over time, as
commercialvendorseliminateproductsfromtheircatalogs.
In addition to this core collection of 135 core articles, we added 86 additional
publicationstoourstudythroughacollaborationwiththeZebraﬁshInformationNetwork
(ZFIN), who agreed to assess identiﬁability of reported resources according to our
evaluationguidelinesaspartoftheirestablishedcurationpipeline.Finally,asetof17more
articlesfromtheNathanUrbanLaboratoryatCarnegieMellonUniversitywasincludedin
ourexperiment.TheUrbanLabstudiescellularandsystemsneuroscience,andextensively
uses animal models and antibodies. These articles were included to explore how the
thoroughandstructureddocumentationpracticesofthislabinitsinternalmanagementof
resource inventory and usage is reﬂected in its reporting of materials in the literature they
produce. Articles from these additional ZFIN and Urban Lab collections were also classi-
ﬁedaccordingtodisciplineandimpactfactor,soastobeincludedwithourcorecollection
in our factor analysis. In total, 238 manuscripts were analyzed from 84 journals. All of the
articles contained at least one or more of the research resources we evaluated in this study.
To ensure this was a suYcient number of papers, we did preliminary statistical analysis to
determine that we could ﬁnd statistical signiﬁcance in the results. A list of the journals,
domains, impact factors, and PubMed IDs, as well as the complete dataset is available in
TableS1.
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A team of three curators evaluated a selection of articles from the corpus, with each
being reviewed by a single expert to identify and establish the identiﬁability of each
documented resource. In addition, zebraﬁsh and ﬂy genetics experts curated the zebraﬁsh
and drosophila model organisms, respectively, as our primary curators did not have
expertise in these areas. We performed spot-checking of the primary curation and
issues found by the secondary evaluator were documented in the curation spreadsheets
and updates were made to the curation guidelines. Where necessary, the curator used
supplemental data and any referenced articles or publically accessible online data sources,
dating as far back as necessary to ﬁnd uniquely identifying information about a resource.
This included vendor catalogs and a variety of experimental and resource databases,
where identifying information was often resolvable based on information provided in a
publication. More detailed evaluation criteria for unique identiﬁcation of each resource
type are described below. For a given article, evaluation of only the ﬁrst ﬁve resources of
each type was performed in the core publication collection. This was necessary as some
papers referenced a cumbersome number of resources such as antibodies or RNAi oligos,
whichweretypicallyreportedtothesamedegreeofrigor.
Resource identiﬁcation criteria
Based on our extensive experience in working with these particular resources and on
consultation with several external experts, we developed a set of criteria to determine the
ability of each resource type to be ‘uniquely identiﬁed’. Generally, ‘unique identiﬁcation’
requiresthataspeciﬁcresourcecanbeobtainedorcreatedbasedoninformationprovided
in or resolvable from the publication directly, or resolvable through referenced literature,
databases, or vendor sites. Below we outline some general and resource-type speciﬁc
requirementsfor‘identiﬁability’appliedinourevaluations.
GENERAL CONSIDERATIONS
Catalog numbers
For commercial resources, provision of a catalog number and the name of the vendor
that resolves to a single oVering uniquely identiﬁes a resource. In the absence of a
catalog number, if provision of only the vendor and resource name allows unambiguous
resolutiontoasingleoVering,aresourceisconsideredidentiﬁable.Forexample,reporting
“polyclonal anti-HDAC4 from Santa Cruz” resolves to a single antibody in the Santa Cruz
catalog even without a catalog number. However, this is not ideal, because the catalog
may expand to include additional polyclonal anti-HDAC4 antibodies in the future, which
would render the resource unidentiﬁable. Additionally, catalog numbers are not stable as
products are discontinued or sold; hence we also looked for a record of the antibody in
theAntibodyRegistry(www.antibodyregistry.org),whichprovidesstableIDsforantibody
oVers.
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Sequence identiﬁcation is a central aspect of identiﬁability for many resource types.
Examples include specifying the sequence of an immunogenic peptide for a lab-sourced
antibody, the sequence of a DNA insert of a construct, or the sequence of a transgene
incorporated into the genome of an organism or cell line. In such cases, these sequences
need to be resolvable to known information about the speciﬁc nucleic acid or peptide
sequence to support identiﬁability of the resource to which they are related. Criteria
that establish resolution of a sequence in support of identifying a dependent resource
include: (1) directly providing the full sequence; (2) referencing a resource from which
the sequence can be determined (to the extent that it is known)—e.g., by providing
a gene ID or accession number that can be looked up and a sequence determined;
(3) when precise/complete sequence information does not exist, a sequence should be
tied to some other unique entity, such as a single, unique source and procedure through
which the physical sequence can be obtained/replicated (e.g., primers and a speciﬁc
source of template DNA such as a uniquely identiﬁed cell type or biological sample).
The requirement for complete resolution to a speciﬁc sequence is not absolute as it is
sometimes the case that this information is not known, and for some resource types
a complete sequence may not be required to be considered uniquely identiﬁable. One
recurring theme we encountered in our study was authors referencing a gene name or
sequence to identify cDNA or a peptide related to the gene. This can be problematic,
as speciﬁcation of a gene sequence may not be suYcient to resolve a single cDNA or
peptidesequence.ThisisbecauseasinglegenemayresolvetomanydiVerenttranscriptsor
peptides(e.g.,throughalternativesplicing),whichcanpreventunambiguousresolutionof
agenesequencetoacDNAorpeptidesequence.
SPECIFIC RESOURCE IDENTIFICATION CRITERIA
Antibodies
Unique antibody identiﬁcation required at least one of the following: (1) an identiﬁer
resolving to a universal registry/database identiﬁer such as the Antibody Registry (www.
antibodyregistry.org)oreagle-irepository(http://www.eagle-i.net),oravendornameand
catalog number for resolving to a single oVering; (2) for antibodies not publicly available,
suYcient protocol details on production of the antibody so as to allow reproduction. This
detail minimally includes specifying the host organism and identity of the immunogen
used. For peptide immunogens, criteria for sequence identiﬁcation above apply, i.e., that
animmunogenicproteinorpeptideresolvestosinglegeneproductsequence.Notethatthe
criteria for identiﬁability do not include the lot or batch number, although a case could be
madeforthislevelofgranularity.
Organisms
For ‘wild-type’ organism strains, an unambiguous name or identiﬁer, such as a stock
number, the oYcial International Mouse Strain Resource (IMSR) name or a MOD
number, is required as well as a source vendor, repository, or lab. For genetically modiﬁed
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includinggeneticbackgroundandbreedinginformation,andprecisealterationsidentiﬁed
in or introduced into the genome (including known sequence, genomic location, and
zygosity of alterations). For random transgene insertions, it is not required that genomic
location of insertion(s) is known, but precise sequence of inserted sequence should be
unambiguouslyresolvableaccordingtosequenceidentiﬁcationcriteriaabove.Fortargeted
alterations, genomic context of the targeted locus and the precise alterations to the locus
should be speciﬁed according to sequence identiﬁcation criteria above. This information
can be provided directly, or through reference to a MOD record or catalog oVering where
suchinformationisavailable.TheMODsprovidespeciﬁcnomenclatureguidelinesthatare
consistentwiththeseviews.
Cell lines
For standard publically available lines, an unambiguous name or identiﬁer is required as
well as a source for the line (e.g., a vendor or repository). This information should resolve
to data about the organismal source and line establishment procedures. For example,
a common cell line reported that can be obtained from ATCC would be considered
identiﬁable, however, if only the name of the line is mentioned without any other
identifying information then it is considered unidentiﬁable. For novel lab-generated
cell lines, an organismal source (species and known genotype information, anatomical
entity of origin, developmental stage of origin) and any relevant procedures applied to
establish a stable lineage of cells. Additionally, some indication of passage number is
recommended but not strictly required. For genetically modiﬁed lines, identiﬁability
criteria are analogous to those for genetically modiﬁed organisms, including genomic
locationandzygosityorcopynumberofmodiﬁcationswherethisinformationisknown.
Constructs
Construct backbone should be unambiguously identiﬁed and resolvable to a complete
vector sequence (typically through a vendor or repository). The sequence of construct
inserts should be identiﬁable according to sequence identiﬁcation criteria above. Most
expression constructs incorporate cDNA—so it is particularly important that the exons
included in this insert are resolvable when more than one splice variant exists for a
gene transcript. This means that specifying the name of a gene or a protein expressed
may not be suYcient if this does not allow for unambiguous resolution to a cDNA
sequence. Identiﬁcation does not require precise description of MCS restriction sites
used for cloning, but this information is encouraged. Relative location and sequence of
epitope tags and regulatory sequences (promoters, enhancers, etc.) should be speciﬁed
(e.g., ‘N-terminal dual FLAG tag’ is suYcient). For example, referencing the accession
number and the vector backbone is suYcient to identify the construct, as in: “for the
full-length Dichaete construct, the insert was ampliﬁed from the full-length cDNA clone
(GenBank accession X96419 and cloned into the HindIII and KpnI sites of pBluescript II
KS(!)” (Shen, Aleksic & Russell, 2013). However, in most constructs, such level of detail is
omitted.
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Identiﬁability requires speciﬁc and complete sequence identiﬁcation according to the
criteria outlined above. This will typically be direct reporting of the sequence, as these
are generally short oligos. For example, this text provided in the method section was
considered identiﬁable: “The DNA target sequence for the rat Egr-2 (NM 053633.1)
gene was CAGGAUCCUUCAGCAUUCUTT” (Yan et al., 2013). In cases where sequence
informationwasnotprovided,thereagentwasconsideredunidentiﬁable.
Statistical analysis
Since the data was binomial in that each resource was either identiﬁable or not, we used
a binomial conﬁdence interval strategy for calculating upper and lower 95% conﬁdence
intervals (CI) (http://www.biyee.net/data-solution/resources/binomial-confidence-
interval-calculator.aspx). Error bars for the corresponding 95% CI are displayed on the
graphs.Statisticalsigniﬁcancewasdeterminedbycalculatingthez-score.
RESULTS AND DISCUSSION
The goal of our study was to determine the proportion of research resources of ﬁve
common types that can be uniquely identiﬁed as reported in the literature. ‘Unique
identiﬁcation’requiresthataresourcecanbeobtainedorre-createdbasedoninformation
provided in or resolvable from a publication. The criteria for identiﬁability were
established a reasonable level of granularity, recognizing that ﬁner levels, e.g., lot or litter
number, may be possible. Establishing identiﬁability criteria was central to our eVort, and
these criteria are complex and varied between resource types as described in the Methods
section.Theresultsofourstudyprovidequantiﬁcationofthisproblemintheliterature.In
total,only54%(922/1703)ofevaluatedresourceswereuniquelyidentiﬁable.Considerable
variability was found across resource types (Fig. 1A), which may result from the inherent
diVerences in the attributes relevant to their identiﬁcation, or from the level of external
support for applying identiﬁers and metadata for their unique identiﬁcation. In addition,
the level of identiﬁability for each resource type is tied directly to the stringency of the
criteria that were separately developed for each, which are unavoidably exposed to some
degreeofsubjectivity.
Antibodies
Antibody reagents represent one of the most challenging and important resource types to
adequately identify, given their ubiquitous use, expense to create, and condition-speciﬁc
eYcacy.Themostcommonissuewithreportingofantibodieswasalackofcatalognumber
(for commercial antibodies) or a lack of reference to the immunogen used to generate
the antibody (for non-commercial antibodies). A separate analysis of commercial versus
non-commercial (e.g., lab-made) antibodies showed an average of 46% of commercial
antibodies, and similarly, 43% of non-commercial antibodies were identiﬁable. While
commercial suppliers do an acceptable job of providing basic metadata about their
oVerings (for example, see http://datasheets.scbt.com/sc-546.pdf), the market is ﬂooded
with products of variable quality metadata. In practice, the literature is where most
Vasilevsky et al. (2013), PeerJ, DOI 10.7717/peerj.148 8/22Figure1 Resourceidentiﬁabilityacrossdisciplines.(A)Summaryofaveragefractionidentiﬁedforeachresourcetype.(B–F)Identiﬁabilityofeach
resource type by discipline. The total number of resources for each type is: (B) antibodies, n D 703; (C) cell lines, n D 104; (D) constructs, n D 258;
(E) knockdown reagents, n D 210; (F) organisms, n D 428. The y-axis is the average for each resource type across each domain. Variation from this
average is shown by the bars, error bars indicate upper and lower 95% conﬁdence intervals.
scientists look when searching for the right antibody for their work, as evidenced by a
marketing report from 1 Degree Bio (http://1degreebio.org/) showing 63% of researchers
use journal references to guide antibody selection (A Hodgson, unpublished data). This
makes it all the more troubling that only 44% of antibodies evaluated in our study could
be uniquely identiﬁed (Fig. 1B). While reporting of a catalog number alone is considered
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wereprovidedforonly27%ofantibodiesweevaluated.
A likely reason for the shortcoming in commercial antibody identiﬁcation may be that
journal reporting guidelines rarely require catalog numbers be reported for antibodies
(or any other reagent type for that matter). More commonly, only a name and location
of a manufacturer are required. For example, the journal “Immunology” simply states:
“Materials and Methods: suYcient information must be included to permit repetition
of experimental work. For specialist equipment and materials the manufacturer (and
if possible their location) should be stated” (Wiley Online Publishing). By contrast, the
Journal of Comparative Neurology (JCN) is one of the rare journals that do require more
precise reporting of antibody metadata, including their catalog number. An extensive
evaluation of 6,510 antibodies in the JCN Antibody Database (Wiley Online Publishing,
2013) revealed that a catalog number was reported in over 90% of the antibodies captured
in their database (AE Bandrowski, NA Vasilevsky, MH Brush, MA Haendel, V Astakhov, P
Ciccarese,JMcMurryandMEMartone,unpublisheddata,andre-evaluatedinthisstudy).
This highlights how a simple solution such as requiring catalog number reporting can
vastlyimproveresourceidentiﬁcationintheliterature.
Notably, as more data is becoming available about protein structure, localization, and
function, the identity of peptide immunogens and epitopes used in creating an antibody
becomes increasingly valuable for explaining its performance in diVerent applications.
Identiﬁcation and tracking of immunogens is one area where there is considerable room
for improvement among vendors and resource databases. EVorts such as the Immune
Epitope Database (IEDB) (http://www.iedb.org/), a manually curated repository of
immunological data about epitope recognition, can be looked to for guidance in how
to capture and represent relevant data about such epitopes. The IEDB curates papers that
report discovery of new epitopes and even in this very speciﬁc use case where the goal is
to report on the speciﬁc epitope, only 81% of the epitopes they curated had the epitope
sequenceprovidedinthepublishedmanuscript(RVita,unpublisheddata).
Cell lines
A source for cell lines was rarely reported and the lack of source was the most common
factorfortheirlowidentiﬁabilityinourstudy.Forcommonlyused,unmodiﬁedlinessuch
as HEK293T cells, our guidelines required a source be provided in addition to the line
name. This information was deemed important given the tendency of lines propagated in
isolation to diverge genetically through continuous passages (Hughes et al., 2007). There
areincreasinglydocumentedoccurrencesofcelllinemisidentiﬁcationandcontamination,
ashighlightedbytheinfamousHeLacontaminationstatistics(Gartler,1968)andothercell
linecontaminations(Phuchareonetal.,2009).Simplyreportingthenameofthelinewith-
out a source fails to provide any information on the history and integrity of the line. For
lab-generated or genetically modiﬁed cell lines not available from a public source, identi-
ﬁcation required a basic description of the line’s establishment procedure, its anatomical
source,and/ortheprecisegeneticmodiﬁcationsmade(seedetailsinMethodssection).
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antibodies, averaging 43% across all disciplines (Fig. 1C). A notable diVerence was found
for cell line identiﬁability between our lowest and highest reporting disciplines—General
Biology (0% identiﬁable) and Immunology (88% identiﬁable). This may reﬂect the
tendency for less rigorous reporting requirements and reduced space allocation for
methods that are common in high-proﬁle journals we included in this category (e.g.,
Nature, Science). By contrast, the majority of cell lines reported in Immunology papers
adequately referenced either the lab, investigator, or commercial supplier that provided
the cell line, which may indicate more rigorous conventions for sharing and attribution
for cell lines in this community; however, due to the low number of cell lines evaluated in
immunologyjournalsinthisstudy,wecannotmakethisconclusion.
An important aspect of cell lines that we found highly neglected in literature reporting
was passage number. This attribute provides an important metric to gauge the integrity
of a cell line sample, and how likely it is to be faithfully reﬂected in another sample. We
found such information to be rarely reported in our study, and thus did not require it
in addition to a source for identiﬁability. But we highly recommend more attention be
paid to tracking and reporting this important attribute in the literature. This practice is
particularly important for lines propagated in research labs, as a survey on cell line usage
reported that 35% of researchers use cell lines obtained from another lab rather than a
cell line repository (Buehring, Eby & Eby). Tracking passage number and contamination
is a lower priority in these labs compared to commercial repositories, such that the use of
geneticallyorcompositionallydivergentsamplesofthesamelineislikelytobeasigniﬁcant
contributor to diYculties in reproducing cell-line based research. Towards this end, a
guideline has been published to check for contamination and authenticity of cell lines
(Capes-Davisetal.,2010).
DNA constructs
Unique identiﬁcation of constructs was the lowest amongst all resource types examined,
onaverage25%wereidentiﬁable,duetolackofreportingofsequenceorotheridentifying
information(Fig.1D).Thiswaslikelyduetothedependencyofidentiﬁcationonreporting
a complete or approximated sequence, and the lack of incentive, guidelines, or technical
support for providing such metadata. While many construct backbones are obtained
from commercial manufacturers where the relevant sequence information is provided,
the valuable component of a construct are the gene(s) that have been sub-cloned in by
a researcher. Access to this sequence information is critical in order to reproduce the
experiment or fully utilize these resources, but it is rarely directly reported in full. While
resources like Addgene and PlasmID provide detailed information about constructs and
therelevantgenecomponents,submissionofplasmidstosuchrepositoriesisinfrequent,as
we found less than 10% of non-commercial plasmids reported in our corpus to be present
in such repositories. In cases where primer sets were used to generate a construct insert,
we often found that the primer sequences were reported; yet the speciﬁc and complete
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determinethesequenceoftheproductclonedintoaconstruct.
Gene knockdown reagents
Knockdownreagentsweresigniﬁcantlymoreidentiﬁablecomparedtotheformerresource
types mentioned above, at 83% (Fig. 1E). Knockdown reagents are frequently used, in
particular in Cell and Developmental Biology (Harborth et al., 2001; Nasevicius & Ekker,
2000). Identiﬁability of knockdown reagents was the highest amongst resource types.
This is likely due to the fact that knockdown reagents tend to be comprised of short,
and therefore easy to include, sequence information. Additionally, editors often require
reportingofsequencesforcustomreagents,asthisinformationiscriticaltounderstanding
andverifyingthereagentfunction.MODsalsokeeptrackofthesesequencesastheycurate
papers. The majority of knockdown reagents that were curated in this study were from
DevelopmentalBiologyjournals,whichalsohadthelowestnumberofidentiﬁablereagents
compared to other ﬁelds. Knowing the exact sequence used is necessary to reproduce
the experiment, and concentration and experimental details are similarly important to
determineoV-targeteVects.
Organisms
Organisms showed a relatively high identiﬁability of 77% (Fig. 1F). Amongst organisms,
yeast were the most identiﬁable (100%, albeit there were only 5 strains analyzed from one
paper), followed by zebraﬁsh (87%), ﬂies (80%), mice (67%), and rats (60%). Worms
and frogs were the least identiﬁable, at 58%, 33%, and 0%, respectively. The identiﬁcation
of transgenic organisms was higher, with 83% of transgenic organisms being identiﬁable
compared to 46% of non-transgenic wild type strains. The higher identiﬁability may be
due to the fact that 56% of the transgenic strains we analyzed had already been curated
by a MOD, because the organisms reported in our corpus were previously reported in an
earlier publication that had been curated by a MOD. Indeed, identiﬁability of organisms
not found in a MOD was considerably lower at 60%. The MODs review the current
literatureandannotateinformationaboutgeneticmodiﬁcationsusedintransgenicstrains,
phenotypes, gene expression, etc., in addition to other relevant types of information
pertaining to the organisms (Bradford et al., 2011; Bowes et al., 2010; Yook et al., 2012;
Marygold et al., 2013; Laulederkind et al., 2013; Bult et al., 2013). While it is reassuring that
thesespeciﬁcstrainshavebeenpreviouslycuratedviaearlierpublications,itoftenrequires
the curator to dig through many publications or to contact the authors directly. ZFIN
determinedthatoveratwo-monthperiod,theyhadtocontact29%ofauthorstoproperly
curatetheresourcesreportedintheirmanuscript.
Comparing organism identiﬁcation between disciplines, we noted that they were con-
siderablylessidentiﬁableinNeurosciencepapers(46%)relativetootherdomains.Alikely
explanation is that non-transgenic animals are commonly used in neuroscience assays
such as electrophysiology studies (26 out of 62 organisms analyzed were non-transgenic).
Identiﬁcationofsuchcommerciallyavailablestrainsfacessimilarproblemsasstandardcell
lines,whereasourceisrequiredtoallowsomehistoricalinformationtobeobtainedabout
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wild type strains of model organisms (Portelli et al., 2009; Sandberg et al., 2000; Wahlsten,
1987),andvariationsbetweensuppliers(Ezerman&Kromer,1985).
Domain considerations
We further examined if the unique identiﬁcation of resources diVered between sub-
disciplines of biomedical research (Table 1). While no discipline was consistently above
or below average with respect to identiﬁcation of the resources, Developmental Biology,
General Biology, and Immunology were generally above average compared to the other
ﬁelds. The identiﬁcation of cell lines was highest in Immunology papers, which was
signiﬁcantly diVerent from Cell and General Biology papers, and papers from the “other”
category, even though there was a small sample size (16 out of 104 total cell lines were
from Immunology journals). By contrast, no cell lines were identiﬁable in the General
Biology papers, which was signiﬁcantly lower compared to all disciplines except the
“other” category. However, General Biology journals boasted the highest percentage of
identiﬁable constructs in papers at 59%, which was a signiﬁcantly better compared to
the other disciplines except Immunology. It is notable that identiﬁcation of resources for
Neuroscience was below average compared to the other ﬁelds for all resources except cell
lines. Of note, identiﬁcation of organisms in Neuroscience journals was signiﬁcantly less
than all other disciplines (30 out of 62 organisms were identiﬁable). Overall, there was
not a consistent trend between scientiﬁc sub-domains with respect to identiﬁability of
resources(Figs.1B–1F).
Impact factor considerations
We next examined whether identiﬁcation of resources diVered among journals across a
range of impact factors. We found that resource identiﬁcation did not vary with journal
impactfactor,asrevealedbythelackofcorrelationinscatterplotanalysis(Figs.2A–2E).
Analysis by reporting requirements
Very few journals were considered to have stringent reporting requirements, and amongst
those, it was surprising to note that the identiﬁcation of the resources did not appear
improved in journals with satisfactory or loose reporting requirements. Identiﬁcation
of cell lines was especially poor in journals with satisfactory reporting guidelines (0
out of 21 were identiﬁable, from 10 articles analyzed), and overall, the identiﬁcation
of the resources was the poorest in journals with highest reporting requirements (an
average of 45% were identiﬁable in journals with stringent reporting requirements,
while resources from journals with satisfactory and loose were on average 61% and 55%
identiﬁable, respectively; Fig. 3). On average, journals with loose reporting requirements
had a signiﬁcantly higher percentage of identiﬁable resources compared to journals with
stringentreportingrequirements.
Withmostjournalshavingalowormid-levelimpactfactor(i.e.,askeweddistribution),
the majority of high identiﬁability therefore comes from these lower proﬁle journals.
This is an encouraging result, because it means that the lion’s share of the publishing
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Resourcetype Domain Totalnumber
identiﬁable
Totalnumber
ofresources
Totalnumber
ofpapers
Percentage
identiﬁable
Antibody Cell biology 69 149 34 46%
Dev biology 68 144 44 47%
General biology 36 74 19 49%
Immunology 48 124 28 39%
Neuroscience 60 136 41 44%
Other 31 76 24 41%
Grandtotal 312 703 190 44%
Celllines Cell biology 15 38 17 39%
Dev biology 7 12 5 58%
General biology 0 10 5 0%
Immunology 14 16 6 88%
Neuroscience 4 7 6 57%
Other 5 21 9 24%
Grandtotal 45 104 48 43%
Constructs Cell biology 16 84 17 19%
Dev biology 18 66 19 27%
General biology 16 27 8 59%
Immunology 3 8 3 38%
Neuroscience 4 35 7 11%
Other 7 38 12 18%
Grandtotal 64 258 66 25%
Knockdownreagents Cell biology 40 49 16 82%
Dev biology 55 76 22 72%
General biology 31 31 9 100%
Immunology 5 5 3 100%
Neuroscience 9 12 6 75%
Other 35 37 14 95%
Grandtotal 175 210 70 83%
Organisms Cell biology 57 70 27 81%
Dev biology 119 141 44 84%
General biology 30 36 11 83%
Immunology 38 48 20 79%
Neuroscience 30 62 38 48%
Other 57 71 28 80%
Grandtotal 331 428 168 77%
Overall total 927 1703 54%
world has already demonstrated a capability of producing identiﬁable resources. It is
especially important to not overlook these higher volume lower-cited journals to produce
quality metadata about research resources. Additionally, higher impact journals tend to
de-emphasize methods over other sections. Therefore, what is needed is to incentivize all
journalstodobetterwithrespecttoidentiﬁability.
Vasilevsky et al. (2013), PeerJ, DOI 10.7717/peerj.148 14/22Figure 2 Resource identiﬁcation rates across journals of varying impact factors. (A) An overview of fraction identiﬁed by impact factor for all
resource types. (B–F) Fraction identiﬁed by impact factor for each individual resource type. Increasing height on the x-axis corresponds with a
higher impact factor for each journal.
Lab documentation vs. publications
For the Urban lab publications that we evaluated, only 44% of the antibodies used were
identiﬁable (out of 9 total antibodies from 5 papers), and 47% of the organisms were
identiﬁable (out of 17 organisms from 17 papers). We note that this lab internally keeps
highly structured notes and metadata about their resources in the lab; after analyzing
their internal notes, 100% of antibodies and 100% of organisms were identiﬁable using
our criteria. However, despite this information being tracked extensively within the
lab, these details did not make it into their publications. It does suggest, however, that
the information is potentially recoverable, if practices to make resources identiﬁable are
implemented.
Evaluation criteria and workﬂow
A core challenge of designing this experiment was determining evaluation criteria that
were precise enough to allow for reproducible determination of reported resource
identiﬁability. For simplicity, we used a binary classiﬁcation for the data analysis, but in
Vasilevsky et al. (2013), PeerJ, DOI 10.7717/peerj.148 15/22Figure 3 Identiﬁcation of resource varies across journals with varying resource-reporting require-
ments. The classiﬁcations of reporting requirements are summarized in the methods. A total of 53
out of 118 resources were identiﬁable in the stringent reporting guidelines category (17 papers were
analyzed), 201 resources were identiﬁable out of 329 resources for the satisfactory category (48 papers
were analyzed) and 662 out of 1,217 resources were identiﬁable in the loose category (182 papers were
analyzed). Variation from this average is shown by the bars, error bars indicate upper and lower 95%
conﬁdence intervals.
reality the amount of information pertaining to resource identiﬁcation was incremental.
Crafting of these criteria required careful consideration of each resource type, including
how they are generated and acquired and the particular aspects of each that are important
inthecontextofexperimentalreproducibility.Thiswasparticularlycomplexforresources
whose identiﬁcation required sequence information relating to a target or part of the
resource, as diVerent applications may require diVerent degrees of speciﬁcity. Despite
the abundance of public databases that provide identiﬁers for biological sequences, we
found a reluctance of authors to reference such IDs when documenting reagents such as
constructs or antibodies. This may point to a lack of awareness, a lack of incentive, or a
lack of means for the journals and authors to use existing resources to supply uniquely
identiﬁable information. Each problem is likely to have its own set of solutions, which we
discussinourrecommendationsbelow.
To ensure their consistent application, criteria and evaluation workﬂows were centrally
documented, performed, and evaluated performed by expert biocurators. These results
support the speciﬁcity and reproducibility of our guidelines, which we hope will serve to
inform reporting requirements of publishers and the development of support platforms
forauthors.
CONCLUSIONS
Improving reporting guidelines for authors is an important step towards addressing
this problem. Very few journals (only 5=83) had high stringency guidelines by our
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requirements, usually due to space limitations in the journal and often required reference
to previously published methods. It has also been previously noted that higher impact
journals have a higher retraction rate (Fang, Casadevall & Morrison, 2011). The Journal
of Comparative Neurology has stringent reporting standards for materials and methods,
requiring that sources for all materials and equipment, sequence information for nucleic
acids and peptides, and immunogen and catalog number for antibodies be reported.
It is our hope that other journals will follow suit. That said, we found that antibody
identiﬁability in the Journal of Comparative Neurology was only slightly higher than
average across all journals (58% in JCN vs. 44% overall). Our ﬁndings are also much
lower than the percentage calculated from the JCN database above, perhaps due to lack of
compliance by authors or lack of enforcement by reviewers. Based on the sampling that
we have, there does not seem to be any relationship between reporting guidelines and
identiﬁability.Onemightask,howcanthisbe?Therealityisthathavingqualityguidelines
forauthorsisonlyonepartofthesolution.Forexample,MikeTaylorwritesabouthowthe
peerreviewprocessfailstoenabletrustworthyscience(Taylor,2013).
The solution to improving resource identiﬁability and therefore scientiﬁc repro-
ducibility needs to be a partnership between all participants in the scientiﬁc process,
and deﬁciencies in awareness and diYculties coordinating across these stakeholders is at
the root of the problem. Better tracking of research resources by researchers during the
course of research can facilitate sharing of information with databases and at publication
time. Electronic lab notebooks and management software (Machina & Wild, 2013;
Hrynaszkiewicz, 2012), or resource sharing repositories such as the eagle-i Network
(www.eagle-i.net) (Vasilevsky et al., 2012) or the Neuroscience Information Framework
(http://www.neuinfo.org/) (Bandrowski et al., 2012) enable creation of stable identiﬁers
and structured tracking of information. The MODs have recommended nomenclature
standards for organisms, but these are not always adhered to (Eppig & Levan, 2005;
MGI, 2013; ZFIN, 2013; Flybase, 2013). In an ideal situation, authors would report the
unique ID pertaining to the model organism directly in the publication by having their
ID assigned and nomenclature approved prior to publication. Then a direct link and easy
accesstotheinformationtoresearcherswhoareattemptingtounderstandorreproducean
experimentcanbemadeavailable.Inaddition,thiscanfacilitatetext-miningandmachine
processing using automated agents that recognize these IDs. Journal editors should better
detail reporting requirements, such as in the recent communiqu´ e from Nature (http://
www.nature.com/authors/policies/reporting.pdf). Publishers also need functionality to
identify resources at the time of submission. Tools such as the DOMEO Toolkit allow
for semantic markup of papers (Ciccarese, Ocana, & Clark , 2012) and can be utilized
during the submission process whereby researchers can easily check the identiﬁability of
the resources found in their paper. Vendors, if more aware of how their products are being
referencedintheliteratureanddatabases,maytendtowardsbetterandmorestablecatalog
schemes as well as to integrate the added knowledge being captured in external resources.
Finally,researcherscanbeattributedfortheirresourcessothattheywouldbeincentivized
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speciﬁcareawhereuniquelyidentifyingsuchresourcescanhaveapositiveinﬂuenceonthe
evaluation of one’s scholarly activities. Similarly, the Bioresource Research Impact Factor
(BRIF) (Mabile et al., 2013) provides attribution for use and sharing of resources. Unique
reference of resources through databases such as the Antibody Registry, eagle-i or MODs
canfacilitatethisprocess.Finally,researchersneedtoknowwheretheinformationintheir
favorite online resources comes from—the literature and the biocurators that curate their
papersanddatasets.Identiﬁabilityisjustasimportantinthecontextofdatasets,andgiven
the signiﬁcant eVort being made to make informatics analyses reproducible (http://www.
runmycode.org/CompanionSite/) and data sets available (dryad.org, figshare.com/), it is
ironicthatinsomecasestheoriginaldataitselfmaynotbereproduciblesimplybecausethe
antibodyusedtogeneratethedatawasneverspeciﬁed.
Scientiﬁc reproducibility is dependent on many attributes of the scientiﬁc method.
Being able to the uniquely identify the resources used in the experiments is only one of
these attributes—it just happens to be the easiest one to accomplish. We hope that this
study insights authors, reviewers, editors, vendors, and publishers to work together to
realizethiscommongoal.
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